Comparison of outcomes in patients with stage III versus limited stage IV non-small cell lung cancer

Radiation Oncology

Volumn 6, Issue 1, 2011, Pages

  Cheruvu, Praveena ^a   Metcalfe, Su K ^a   Metcalfe, Justin ^a   Chen, Yuhchyau ^a   Okunieff, Paul ^b   Milano, Michael T ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Non Small Cell Lung Cancer; Oligometastases; Stereotactic Body Radiotherapy

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; COHORT ANALYSIS; COMPARATIVE STUDY; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MEDICAL INSTRUMENTATION; MEDICAL RECORD REVIEW; METASTASIS; OLIGOMETASTASIS; OUTCOMES RESEARCH; OVERALL SURVIVAL; PATIENT POSITIONING; PROGNOSIS; RADIATION DOSE; RETROSPECTIVE STUDY; STEREOTACTIC BODY RADIATION THERAPY; TREATMENT OUTCOME; LUNG TUMOR; METHODOLOGY; MIDDLE AGED; PALLIATIVE THERAPY; RADIOTHERAPY; RECURRENT DISEASE; SMOKING; WEIGHT REDUCTION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; PALLIATIVE CARE; RADIOTHERAPY; RECURRENCE; RETROSPECTIVE STUDIES; SMOKING; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 79959685126     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-6-80     Document Type: Article

References (31)

1. Jemal A, Siegel R, Xu J, Ward E. Cancer Statistics, 2010. CA Cancer J Clin 2010, 60(5):277-300. Epub 2010 Jul 7, 10.3322/caac.20073, 20610543.
2. Greene FL, Page DL, Fleming ID, Fritz A, Balch CM, Haller DG, Morrow M. AJCC Cancer Staging Manual. 2002, New York: Springer, 6.
3. Hellman S, Weichselbaum RR. Oligometastases. J Clin Oncol 2005, 13:8-10.
4. Timmerman RD, Bizekis CS, Pass HI, Fong Y, Dupuy DE, Dawson LA, Lu D. Local Surgical, Ablative and Radiation Treatment of Metastases. CA Cancer J Clin 2009, 59:145-170. 10.3322/caac.20013, 19364702.
5. Milano MT, Katz AW, Muhs AG, Philip A, Buchholz DJ, Schell MC, Okunieff P. A Prospective Pilot study of Curative Intent Stereotactic Body Radiotherapy in Patients with 5 or fewer Oligometastatic Lesions. Cancer 2008, 112:650-658. 10.1002/cncr.23209, 18072260.
6. Milano MT, Katz AW, Schell MC, Philip A, Okunieff P. Descriptive Analysis of Oligometastatic Lesions Treated with Curative-Intent Stereotactic Body Radiotherapy. Int J Radiat Oncol Biol Phys 2008, 72(5):1516-22. 10.1016/j.ijrobp.2008.03.044, 18495378.
7. Kao J, Packer S, Vu HL, Schwartz ME, Sung MW, Stock RG, Lo YC, Huang D, Chen SH, Cesaretti JA. Phase 1 Study of Concurrent Sunitinib and Image Guided Radiotherapy followed by Maintenance Sunitinib for Patients with Oligometastases: Acute Toxicity and Preliminary Response. Cancer 2009, 115(15):3571-80. 10.1002/cncr.24412, 19536893.
8. Salama JK, Chmura SJ, Mehta N, Yenice KM, Stadler WM, Vokes EE, Haraf DJ, Hellman S, Weichselbaum RR. An Initial Report of Radiation Dose-Escalation Trial in Patients with One to Five Sites of Metastatic Disease. Clin Cancer Res 2008, 14(160):5255-9.
9. Milano MT, Constine LS, Okunieff P. Normal Tissue Toxicity after Small Field Hypofractionated Stereotactic Body Radiation. Radiat Oncol 2008, 3:36. 10.1186/1748-717X-3-36, 2596155, 18976463.
10. Katz AW, Carey-Sampson M, Muhs AG, Milano MT, Schell MC, Okunieff P. Hypofractionated Stereotactic Body Radiation Therapy (SBRT) for Limited Hepatic Metastases. Int J Radiat Oncol Biol Phys 2006, 67:793-798.
11. Okunieff P, Petersen AL, Philip A, Milano MR, Katz AW, Boros L, Schell MC. Stereotactic Body radiation Therapy (SBRT) for Lung Metastases. Acta Oncol 2006, 45:808-817. 10.1080/02841860600908954, 16982544.
12. Choti MA, Sitzmann JV, Tiburi MF, Sumetchotimetha W, Rangsin R, Schulick RD, Lillemoe KD, Yeo CJ, Cameron JL. Trends in Long-Term Survival Following liver resection for Hepatic Colorectal Metastases. Ann surg 2002, 235:759-766. 10.1097/00000658-200206000-00002, 1422504, 12035031.
13. Sternberg DI, Sonett. Surgical Therapy of Lung Metastases. Semin Oncol 2007, 133:967-972.
14. Tanvetyanon T, Robinson L, Schell MJ, Strong VE, Kapoor R, Coit DG, Bepler G. Outcomes of Adrenalectomy for Isolated versus Metachronous Adrenal Metastases in Non-Small- Cell Lung Cancer: A Systematic Review and Pooled Analysis. J Clin Oncol 2008, 26:1142-1147. 10.1200/JCO.2007.14.2091, 18309950.
15. Pfannschmidt J, Dienemann H. Surgical Treatment of Oligometastatic Non-Small Cell Lung Cancer. Lung Cancer 2010, 69:251-258. 10.1016/j.lungcan.2010.05.003, 20537426.
16. Rusthoven KE, Kavanagh BD, Burri SH, Chen C, Cardenes H, Chidel MA, Pugh TJ, Kane M, Gaspar LE, Schefter TE. Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases. J Clin Oncol 2009, 27:1579-1584. 10.1200/JCO.2008.19.6386, 19255320.
17. Kavanagh BD, McGarry RC, Timmerman RD. Extracranial Radiosurgery (Stereotactic Body Radiation Therapy) for Oligometastases. Semin Radiat Oncol 2006, 16(2):77-84. 10.1016/j.semradonc.2005.12.003, 16564443.
18. Lo SS, Sahgal A, Wang JZ, Mayr NA, Sloan A, Mendel E, Chang EL. Stereotactic Body Radiation Therapy for Spinal Metastases. Discov Med 2010, 9(47):289-96.
19. Rusthoven KE, Kavanaugh BD, Cardenes H, Stieber VW, Burri SH, Feigenberg SJ, Chidel MA, Pugh TJ, Franklin W, Kane M, Gaspar LE, Schefter TE. Multi-institutional Phase I/II Trial of Stereotactic Body Radiation Therapy for Liver Metastases. J Clin Oncol 2009, 27(10):1572-8. 10.1200/JCO.2008.19.6329, 19255321.
20. Chang EL, Shiu AS, Mendel E, Mathews LA, Mahajan A, Allen PK, Weinberg JS, Brown BW, Wang XS, Woo SY, Cleeland C, Maor MH, Rhines LD. Phase I/II study of stereotactic body radiotherapy for spinal metastasis and its pattern of failure. J Neurosurg Spine 2007, 7:151-60. 10.3171/SPI-07/08/151, 17688054.
21. Curran WJ, Scott CB, Langer CJ, Komaki R, Lee S, Hauser S, Movsas B, Wasserman T, Sause W, Cox JD. Long-term benefit is observed in a phase III comparison of sequential vs concurrent chemo-radiation for patients with unresected stage III NSCLC: RTOG 9410. Proc Am Soc Clin Oncol(ASCO) 2003, (abstr. #2499):621. Chicago.
22. Gandara DR, Chansky K, Albain KS, Leigh BR, Gaspar LE, Lara PN, Burris H, Gumerlock P, Kuebler JP, Bearden JD, Crowley J, Livingston R. Consolidation Docetaxel After Concurrent Chemoradiotherapy in Stage IIIB Non-Small-Cell Lung Cancer: Phase II Southwest Oncology Group Study S9504. JCO 2003, 21(10):2004-2010.
23. Rusthoven KE, Hammerman SF, Kavanagh BD, Birtwhistle MJ, Stares M, Camidge DR. Is there a Role for Consolidative Stereotactic Body Radiation Therapy Following First-Line Systemic Therapy for Metastatic Lung Cancer? A Patterns-of-Failure Analysis. Acta Oncologica 2009, 48:578-583. 10.1080/02841860802662722, 19373699.
24. Mehta N, Mauer AM, Hellman S, Haraf DJ, Cohen EE, Vokes EE, Weichselbaum RR. Analysis of Further Disease Progression in Metastatic NSCLC: Implications for Locoregional Treatment. Int Journal of Oncology 2004, 25:1677-1683.
25. Khan AJ, Mehta PS, Zusag TW, Bonomi PD, Penfield Faber L, Shott S, Abrams RA. Long term Disease Free Survival Resulting from Combined Modality Management of Patients Presenting with Oligometastatic NSCLC. Radiotherapy and Oncology 2006, 81:163-167. 10.1016/j.radonc.2006.09.006, 17050016.
26. Chawla S, Chen Y, Katz AW, Muhs AG, Philip A, Okunieff P, Milano MT. Stereotactic Body Radiotherapy for Treatment of Adrenal Metastases. Int J Radiat Oncol Biol Phys 2009, 75(1):71-5. 10.1016/j.ijrobp.2008.10.079, 19250766.
27. Lee P, Weerasuriya DK, Lavori PW, Hara W, Maxim PD, Le QT, Wakelee HA, Donington JS, Graves EE, Loo BW. Metabolic Tumor Burden Predicts for Disease Progression and Death in Lung Cancer. IJROBP 2007, 69(2):328-333.
28. Bradley J, Ieumwananonthachai N, Purdy JA, Wasserman TH, Lockett MA, Gramham MV, Perez CA. Gross Tumor Volume Critical Prognostic Factor in Patients Treated with Three Dimensional Conformal Radiotherapy for NSCLC. IJROBP 2002, 52(1):49-57.
29. Basaki K, Abe Y, Aoki M, Kondo H, Hatayama Y, Nakaji S. Prognostic factors for survival in Stage III non-small-cell-lung cancer treated with definitive radiation therapy: impact of tumor volume. IJROBP 2006, 64:449-454.
30. Nishio W, Sakamoto T, Uchino K, Yuki T, Nakagawa A, Tsubota N. Effect of Tumor Size on Prognosis in Patients with Non Small Cell Lung Cancer: the Role of Segmentectomy as a Type of Lesser Resection. J Thoracic Cardiovasc Surg 2005, 129:87-93.
31. Oh Y, Taylor S, Bekele BN, Debnam JM, Allen PK, Suki D, Sawaya R, Komaki R, Stewart DJ, Karp DD. Number of Metastatic Sites is a Strong Predictor of Survival in Patients with Nonsmall Cell Lung Cancer With or Without Brain Metastases. Cancer 2009, 115:2930-2938. 10.1002/cncr.24333, 19441110.